The Sapigen Biotech Vaccine Manufacturing Unit was developed for Bharath Biotech to support large-scale pharmaceutical production with stringent quality and safety requirements. Spanning a total built-up area of 2,10,000 sq. ft., the facility was planned with robust structural systems to accommodate specialized manufacturing zones and controlled environments.
The structural works were completed within an accelerated timeline of 5.5 months, reflecting efficient execution, precise planning, and adherence to high construction and compliance standards. The project plays a vital role in strengthening healthcare infrastructure by enabling reliable vaccine production through durable and future-ready industrial design.
